Interestingly, we have found that disruption of the Scly gene in mice led to obesity with dyslipidemia, hyperinsulinemia, glucose intolerance, and lipid accumulation in hepatocytes, characteristics of a metabolic syndrome-like phenotype. This evidence concerns the gene SCLY and obesity due to melanocortin 4 receptor deficiency.